Dexamethasone approved for use in India for COVID-19
The
government in India has authorized the use of the low-cost steroid drug
dexamethasone as an alternative to methylprednisolone.
This drug will be used to treat coronavirus
patients with moderate and severe symptoms.
Dexamethason
,is a steroid which is used to reduce inflammation in other diseases such as
arthritis, also can be used for patients in need of oxygen support and those
who have excessive inflammatory response.
Indian company headquartered in Ahmedabad.